title: Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin-associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass.
authors.affiliation: Department of Anesthesiology, University of Virginia Health Sciences Center, Charlottesville 22908.
authors.forename: B F
authors.initials: BF
authors.lastname: Spiekermann
authors.forename: C L
authors.initials: CL
authors.lastname: Lake
authors.forename: G F
authors.initials: GF
authors.lastname: Rich
authors.forename: J E
authors.initials: JE
authors.lastname: Humphries
mesh_terms: D000368:Aged; D000721:Ancrod / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D002315:Cardiopulmonary Bypass; D005337:Fibrin / Q000502:physiology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013921:Thrombocytopenia / Q000139:chemically induced*; D013924:Thrombophlebitis / Q000139:chemically induced*; D013997:Time Factors; D014914:Whole Blood Coagulation Time
chemical_list: D005337:Fibrin; D006493:Heparin; D000721:Ancrod